Fig. 2: LOX-1 expression and breast cancer distant metastasis free survival (DMFS).
From: Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes

a Kaplan–Meier plot analysis of LOX-1 expression level (low or high) on breast cancer distant metastasis free survival (DMFS). b Immunohistochemical analysis of LOX- 1 expression in breast cancer phenotypes and healthy counterpart of the same individuals. c Correlation among HER-2 amplification, FASN and LOX-1 overexpression in HER-2-enriched phenotypes (HER-2- FASN positive vs LOX-1: p < 0.01)